1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Tuberous Sclerosis Complex: new trials by email Literature Review of Tuberous Sclerosis Complex trials Research Report on Tuberous Sclerosis Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1) AV078, Placebo - Tuberous Sclerosis Complex, Epilepsy | Phase 2 | Not yet recruiting | Aeovian Pharmaceuticals, Inc. | 42 | 2026-09-01 | 2026-09-29 |
Drug Resistant Epilepsy (1) · Epilepsy (1) · Seizures (1) · Tuberous Sclerosis (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1) · Neoplasms, Multiple Primary (1) · Neoplastic Syndromes, Hereditary (1) · Nervous System Diseases (1) · Nervous System Malformations (1) · Neurocutaneous Syndromes (1)
Aeovian Pharmaceuticals, Inc. (1)
Canada (1)
2025 (1)